COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,440 Articles (22,835 medRxiv, 8,605 bioRxiv)

Most recent first Previous |  Page 2332: Articles 23311-23320  | Next

Identification of 14 Known Drugs as Inhibitors of the Main Protease of SARS-CoV-2
Ghahremanpour, M. M., Tirado-Rives, J., Deshmukh, M., Ippolito, J. A., Zhang, C.-H., Cabeza de Vaca, I., Liosi, M.-E., Anderson, K. S., Jorgensen, W. L.
10.1101/2020.08.28.271957 — Posted: 2020-08-28
Prunella vulgaris extract and suramin block SARS-coronavirus 2 virus Spike protein D614 and G614 variants mediated receptor association and virus entry in cell culture system
Ao, Z., Chan, M., Ouyang, M. J., Olukitibi, T. A., Mahmoudi, M., Kobasa, D., Yao, X.
10.1101/2020.08.28.270306 — Posted: 2020-08-28 Discussion: Onsite | Offsite
SARS-CoV-2 variants with mutations at the S1/S2 cleavage site are generated in vitro during propagation in TMPRSS2-deficient cells
Sasaki, M., Uemura, K., Sato, A., Sanaki, T., Maenaka, K., Hall, W. W., Orba, Y., Sawa, H.
10.1101/2020.08.28.271163 — Posted: 2020-08-28
Replication dynamics and cytotoxicity of SARS-CoV-2 Swedish isolate in commonly used laboratory cell lines
Saccon, E., Krishnan, S., Vinhas, B., Byrareddy, S., Mirazimi, A., Neogi, U., Gupta, S.
10.1101/2020.08.28.271684 — Posted: 2020-08-28
Comparative study of a 3CLpro inhibitor and remdesivir against both major SARS-CoV-2 clades in human airway models
de Vries, M., Mohamed, A., Prescott, R. A., Valero-Jimenez, A., Desvignes, L., O'Connor, R., Steppan, C., Anderson, A., Binder, J., Dittmann, M.
10.1101/2020.08.28.272880 — Posted: 2020-08-28
Long Period Modeling SARS-CoV-2 Infection of in Vitro Cultured Polarized Human Airway Epithelium
Hao, S., Ning, K., Kuz, C. A., Vorhies, K., Yan, Z., Qiu, J.
10.1101/2020.08.27.271130 — Posted: 2020-08-28
Plasmablast-derived antibody response to acute SARS-CoV-2 infection in humans
Huang, K.-Y. A., Tan, T., Chen, T.-H., Huang, C.-G., Harvey, R., Hussain, S., Chen, C.-P., Harding, A., Gilbert-Jaramillo, J., Liu, X., Knight, M., Schimanski, L., Shih, S.-R., Lin, Y.-C., Cheng, C.-Y., Cheng, S.-H., Huang, Y.-C., Lin, T.-Y., Rahikainen, R., Howarth, M., Jan, J.-T., Ma, C., James, W. S., Daniels, R., McCauley, J., Rijal, P., Townsend, A.
10.1101/2020.08.28.267526 — Posted: 2020-08-28
A PCR amplicon-based SARS-CoV-2 replicon for antiviral screening
Kotaki, T., Xie, X., Shi, P.-Y., Kameoka, M.
10.1101/2020.08.28.267567 — Posted: 2020-08-28
A single immunization with spike-functionalized ferritin vaccines elicits neutralizing antibody responses against SARS-CoV-2 in mice
Powell, A. E., Zhang, K., Sanyal, M., Tang, S., Weidenbacher, P. A., Li, S., Pham, T. D., Pak, J. E., Chiu, W., Kim, P. S.
10.1101/2020.08.28.272518 — Posted: 2020-08-28
A Transferable Deep Learning Approach to Fast Screen Potent Antiviral Drugs against SARS-CoV-2
Wang, S., Sun, Q., Xu, Y., Pei, J., Lai, L.
10.1101/2020.08.28.271569 — Posted: 2020-08-28

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).